mutations on the function of the protein. The conservation analysis was performed by comparing different species amino acid sequences. The pathogenicity of variant was interpreted according to American College of Medical Genetics and Genomics guideline (Richards et al., 2015) .
The potential mutations from NGS were validated by Sanger sequencing. Segregation analysis was applied to all participants. Primer pairs were designed by Primer 3, PCR amplifications were performed with forward primer [5'-GGGGCAAACAGTTCTGTCTC-3'] and reverse primer . PCR products were checked on agarose gels and sequenced on an ABI 3,730 DNA sequencer (Applied Biosystems, Foster City, CA, USA). The sequencing results were compared with gene reference sequences in the UCSC hg19 to confirm potential mutations. NM_000117.2 was used as the reference sequence for the coding regions of the EMD gene.
| RE SULTS

| Clinical findings
The proband (III.3 in Figure 1 ), a 50-year-old man, who suffered from occasional palpitations, lower extremities edema and anhelation for over 10 years. In the year 2007, he was admitted to the cardiology department at the first time for auriculo-ventricular block (Figure 2a ). Echocardiography ( Figure 2b ) revealed generalized cardiomegaly.
Serum creatine kinase (CK) level was normal (232.7 U/L, reference range 50-310 U/L). Physical examination showed no significant muscular weakness in his extremities, no scoliosis or contracture of any joints. An initial diagnosis of conduction cardiomyopathy was made. Inquiry of his complementary family history revealed that three of his uncles had sudden death during ages of 48-58 years old and one of his cousins had chest discomfort at 35 years old.
| Genetic findings
Mutation analysis identified an 1-bp insertion (c.253_254insT) in EMD gene exon 3, the frameshift hemizygous mutation resulting in 
| D ISCUSS I ON
X-linked EDMD is mainly caused by EMD mutations. The EMD gene (NM_000117.2) is mapped to chromosome Xq28 and contains 6 exons. The gene EMD encodes a ubiquitous nuclear membrane protein emerin consisting of 254 amino acids, which participates in membrane anchorage to the cytoskeleton (Bione et al., 1994) . It was reported that cardiac involvement is the most important clinical symptom among patients with EMD mutations (Ura et al., 2007; Yuan et al., 2014 ). Cardiomyopathy appears in early adulthood and usually manifests as heart conduction block. Cardiac involvement usually arises after the second decade of life (Ben Yaou et al., 2007) . ECG abnormalities occurrence often precede muscle disease. Cardiac conduction block can occur as early as 12 years of age and its severity is not related to the amount of muscular weakness and contractures (Sumitani, Ishikawa, Ishikawa, & Minami, 1995) . Lack of emerin levels in heart may alter electrophysiology and myocardial cell adhesion, which could lead to conduction block (Sakata et al., 2005) .
X-linked EDMD associated with EMD mutations is clinically heterogeneous, ranging from mild to severe forms (Meinke et al., 2015) .
Different from the typical clinical features, the proband in our study had a medical history of severe arrhythmia and dilated myopathy, while inconspicuous skeletal muscular weakness and normal serum creatine kinase level. The other affected male (III.14), who presented paroxysmal cardiopalmus and slight limb weakness, had currently normal ECG, should be under close monitoring of cardiac function.
Prognosis in EDMD is strongly associated with the severity of cardiac involvement. Continuous follow-up of cardiac function is essential, including female carriers even in the absence of distinct clinical signs. It is crucial to provide prompt cardiac intervention and avoid unexpected lethal heart diseases for these particular patients. This There are only few case reports on the predominant cardiac features of EDMD patients with EMD mutations (Karst, Herron, & Olson, 2008; Sakata et al., 2005; Vohanka et al., 2001; Yuan et al., 2014; Zhang et al., 2014) (Table 1) . Learning from the previous reports, we knew that EMD mutations might be responsible for independent cardiac phenotype with severe heart rhythm defects or presenting as dilated cardiomyopathy, while muscle involvement and joint contractures were mild, localized, or seldom noticeable until the mutation been identified. It is interesting to find that four of the six reported patients were from Asia, whether the atypical X-linked EDMD manifestations were due to incomplete penetrance or racial differences are still unknown. Our findings increase the case numbers of these rare clinical features and may provide research value of Asian patients in EDMD. Although EMD gene is specifically associated with X-linked EDMD, the genotype-phenotype correlations, with special reference to cardiac involvements, still need to be further investigated.
In conclusion, we describe a novel mutation of EMD gene, which provides genetic diagnosis for the atypical X-linked EDMD individuals of the family. We provided scientific guidance and promote early intervention for EDMD patients, which may minimize the harmful effects of the disease.
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